Microsoft word - asc asda e-bulletin oct 04.doc

ASC AND ASDA NSO ANTI-DOPING EMAIL BULLETIN OCTOBER 2004

WADA 2005 PROHIBITED LIST
In late September 2004 the World Anti-Doping Agency released the 2005 Prohibited List (the
2005 List). The 2005 List comes into effect on January 1, 2005.
A summary of the key changes are below:
•
Gonadotrophins (i.e. LH and hCG) previously prohibited in males only are now also prohibited in females. Beta-2 Agonists are now prohibited at all times (however formoterol, salbutamol, salmeterol and terbutaline continue to be permitted via inhalation but an ATUE is required). Agents with anti-estrogenic activity previously prohibited in males only are now also prohibited in females. Intravenous infusions have now been included as an example of a prohibited method of chemical and physical manipulation (except as a legitimate acute medication treatment). Only dermatological preparations of glucocorticosteroids (e.g. skin creams) are no longer prohibited and therefore do not require an ATUE. Diuretics are no longer listed as a substance prohibited in particular sports Diuretics are no longer a specified substance (i.e. an athlete may no longer argue for a reduced sanction) The T:E ratio threshold has been reduced from 6:1 to 4:1.
The 2005 List, Summary of Modifications for 2005 and the 2005 Monitoring Program are
available for download on the WADA website www.wada-ama.org

The following is an overview of the 2005 List:
I. Substances and Methods prohibited at all times (In- and Out-of-Competition)
S2. Hormones and related substances S3. Beta-2 S4. Agents with anti-estrogenic activity S5. Diuretics and other Masking Agents M1. Enhancement of oxygen transfer M2. Chemical and physical manipulation M3. Gene doping II. Substances and Methods prohibited In-Competition (IC) All the Categories under Section I, plus: S6. Stimulants S7. Narcotics S8. Cannabinoids S9. Glucocorticosteroids III. Substances prohibited in Particular Sports Ephedrine, L-methylamphetamine, methylephedrine Cannabinoids All inhaled beta-2 agonists except clenbuterol Probenecid All glucocorticosteroids All beta blockers Alcohol The 2005 Monitoring Program includes: Stimulants (IC only): bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol,

THERAPEUTIC USE EXEMPTIONS (TUES)
Do your athletes need to use a prohibited substance for a legitimate medical reason?
Standard Therapeutic Use Exemptions (TUEs)
If an athlete suffers from a medical condition that a doctor can only treat with a prohibited substance (other than an inhaled asthma medication or a non-systemic glucocorticosteroid which are outlined in the heading below), he or she must check whether the legitimate therapeutic use of the prohibited substance is permitted under the relevant National Sporting Organisation’s (NSO's) anti-doping policy. Before using any prohibited substances athletes must contact their NSO to determine whether their sport's anti-doping rules allow the use of prohibited substances for legitimate therapeutic purposes. If the relevant NSO's anti-doping policy has a provision for standard TUEs the athlete must strictly adhere to the approval procedures. More information on the therapeutic use of prohibited substances and access to standard TUE application forms can be found on the Australian Sports Drug Medical Advisory Committee (ASDMAC) website <www.asdmac.org.au>. Abbreviated Therapeutic Use Exemptions (ATUEs)
Athletes may require to legitimately use: • an inhaled asthma medication (formoterol, salbutamol, salmeterol, terbutaline) • a non-systemic glucocorticosteroid (administered via anal, aural, dermatological, inhalation, intra-articular, nasal and ophthalmological routes) Glucocorticosteroids are contained in some anti-inflammatory preparations. Athletes that need to use these substances must apply for an ATUE, which was previously known as a ‘medical notification’. The World Anti-Doping Agency has developed an ATUE form for athletes to complete prior to using an inhaled asthma medication or non-systemic glucocorticosteroid. This form can be accessed via the ASDA website <www.asda.org.au>. Athletes should always check with their NSO's medical officer to ensure they are following the correct ATUE procedure. Abbreviated TUE forms that have been completed must be sent to the relevant NSO, not
to ASDA or ASDMAC. The NSO should advise ASDA accordingly.
If an athlete is still unsure of what process they must follow in relation to standard and abbreviated TUEs he/she can call the ASDA Hotline (1800 020 506) for further advice. If you require further information on the 2005 WADA Prohibited List or TUEs please visit the WADA website www.wada-ama.org or contact your ASDA Sport Owner.

Source: http://www.sa.canoe.org.au/site/canoeing/sa/downloads/Notices/ASC%20%20ASDA%20E-bulletin%20Oct%2004.pdf